Dozens of patients were put at risk after two of the UK's leading transplant centres continued fitting a heart device - despite knowing of concerns it had a higher mortality rate than its rival ...

CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the ...

The FDA released guidance Aug. 6 on the Medtronic NIM Vital Nerve Monitoring System recall. The recall is in response to 10 reported injuries resulting from false negative responses received while ...

Earlier this month, Medtronic said the FDA granted the indication for its Onyx liquid embolic system (LES) in the U.S. Onyx ...

The U.S. Food and Drug Administration on Tuesday announced a Class 1 recall — the most serious level — affecting more than 26,000 Medtronic devices used to treat brain aneurysms. The recall comes ...

Medtronic is going after Axonics once again, this time with accusations that its competitor in sacral neuromodulation is illegally using Medtronic’s MRI compatibility technology. The accusations come ...

Taking aim at the costly problem of high blood pressure, Medtronic is launching the first placebo-controlled large-scale clinical study of a medical device treatment intended to lower a person's blood ...

Medtronic Plc (NYSE:MDT) reported fourth-quarter 2024 sales of $8.59 billion, beating the consensus of $8.44 billion. Revenue increased 0.5%, as reported, and 5.4% organic. The company’s organic ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best medical device stocks ...